Oat Beta-Glucans Modulate the Gut Microbiome, Barrier Function, and Immune Responses in an In Vivo Model of Early-Stage Colorectal Cancer
Authors:
- Magdalena GuzowskaMGMagdalena Guzowska
- Katarzyna DziendzikowskaKatarzyna Dziendzikowska
- Łukasz KopiaszŁKŁukasz Kopiasz
- Małgorzata GajewskaMGMałgorzata Gajewska
- Jacek WilczakJWJacek Wilczak
- Joanna HarasymJoanna Harasym
- Malwina CzerwińskaMCMalwina Czerwińska
- Joanna Gromadzka-OstrowskaJGJoanna Gromadzka-Ostrowska
Open Access
- 19 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13586
Abstract
Oat beta-glucans (OBGs) are known for their beneficial effects on gut health, including anti-inflammatory and prebiotic effects. The aim of this study was to evaluate the impact of two doses (1% or 3% w/w) of dietary low-molar-mass OBG supplementation on colorectal cancer (CRC) development, immune cell profiles, intestinal barrier protein expression, and microbiota composition in a rat model of CRC induced by azoxymethane (AOM). Microbiome analysis revealed significant differences between the control and CRC groups. OBG supplementation influenced microbial diversity and abundance, particularly increasing the population of beneficial bacteria, such as Lachnospiraceae and Ruminococcaceae, associated with butyrate production. However, higher doses of OBG (3%) led to a decrease in butyrate-producing bacteria and a shift toward higher levels of Akkermansia muciniphila and Enterococcus faecalis. Immune cell profiling showed a higher percentage of T lymphocytes (CD3+) in rats fed a diet supplemented with 3% OBG, both in the intraepithelial (IEL) and lamina propria lymphocytes (LPLs). Immunohistochemical analysis of the large intestine revealed a significantly elevated expression of intestinal barrier proteins, i.e., claudin 3 and 4 in rats receiving 1% OBG, while claudin 7 expression was reduced in early-stage CRC. Gene expression analysis also revealed a significant downregulation of Cldn1 in CRC rats. These findings suggest that dietary OBG supplementation modulates the gut microbiota, immune response, and intestinal barrier integrity, with potential implications for nutritional CRC development prevention and treatment strategies.Keywords
Funding Information
- Narodowe Centrum Nauki (2018/29/B/NZ9/01060)
- Science Development Fund of the Warsaw University of Life Sciences—SGGW (2018/29/B/NZ9/01060)
This publication has 78 references indexed in Scilit:
- A cell-free DNA colorectal cancer screening test promising enhanced accessibility and early detectionInternational Journal of Colorectal Disease, 2024
- Tissue Content and Pattern of Expression of Claudin-3 and Occludin in Normal and Neoplastic Tissues in Patients with Colorectal CancerJournal of Gastrointestinal Surgery, 2022
- Interspecies commensal interactions have nonlinear impacts on host immunityCell Host & Microbe, 2022
- Worrisome Trends in Young-Onset Colorectal Cancer: Now Is the Time for ActionIndian Journal of Surgical Oncology, 2022
- Claudin-7 downregulation induces metastasis and invasion in colorectal cancer via the promotion of epithelial-mesenchymal transitionBiochemical and Biophysical Research Communications, 2019
- The Impact of Dietary Fiber on Gut Microbiota in Host Health and DiseaseCell Host & Microbe, 2018
- ggplot22016
- Impact of low and high molecular weight oat beta-glucan on oxidative stress and antioxidant defense in spleen of rats with LPS induced enteritisFood Hydrocolloids, 2015
- The Interrelationships of the Gut Microbiome and Inflammation in Colorectal CarcinogenesisClinics In Laboratory Medicine, 2014
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001